RUA Life Sciences PLC

FRA:AOHA (UK)  
€ 0.08 (-27.93%) Sep 25
At Loss
P/B:
1.06
Market Cap:
€ 9.12M ($ 10.17M)
Enterprise V:
€ 4.87M ($ 5.43M)
Volume:
-
Avg Vol (2M):
-
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for RUA Life Sciences PLC ( ) from 1990 to Sep 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. RUA Life Sciences PLC stock (FRA:AOHA) PE ratio as of Sep 26 2024 is 0. More Details

RUA Life Sciences PLC (FRA:AOHA) PE Ratio (TTM) Chart

To

RUA Life Sciences PLC (FRA:AOHA) PE Ratio (TTM) Historical Data

Total 1269
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
RUA Life Sciences PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-09-26 At Loss 2024-07-25 At Loss
2024-09-25 At Loss 2024-07-24 At Loss
2024-09-24 At Loss 2024-07-23 At Loss
2024-09-23 At Loss 2024-07-22 At Loss
2024-09-20 At Loss 2024-07-19 At Loss
2024-09-19 At Loss 2024-07-18 At Loss
2024-09-18 At Loss 2024-07-17 At Loss
2024-09-17 At Loss 2024-07-16 At Loss
2024-09-16 At Loss 2024-07-15 At Loss
2024-09-13 At Loss 2024-07-12 At Loss
2024-09-12 At Loss 2024-07-11 At Loss
2024-09-11 At Loss 2024-07-10 At Loss
2024-09-10 At Loss 2024-07-09 At Loss
2024-09-09 At Loss 2024-07-08 At Loss
2024-09-06 At Loss 2024-07-05 At Loss
2024-09-05 At Loss 2024-07-04 At Loss
2024-09-04 At Loss 2024-07-03 At Loss
2024-09-03 At Loss 2024-07-02 At Loss
2024-09-02 At Loss 2024-07-01 At Loss
2024-08-30 At Loss 2024-06-28 At Loss
2024-08-29 At Loss 2024-06-27 At Loss
2024-08-28 At Loss 2024-06-26 At Loss
2024-08-27 At Loss 2024-06-25 At Loss
2024-08-26 At Loss 2024-06-24 At Loss
2024-08-23 At Loss 2024-06-21 At Loss
2024-08-22 At Loss 2024-06-20 At Loss
2024-08-21 At Loss 2024-06-19 At Loss
2024-08-20 At Loss 2024-06-18 At Loss
2024-08-19 At Loss 2024-06-17 At Loss
2024-08-16 At Loss 2024-06-14 At Loss
2024-08-15 At Loss 2024-06-13 At Loss
2024-08-14 At Loss 2024-06-12 At Loss
2024-08-13 At Loss 2024-06-11 At Loss
2024-08-12 At Loss 2024-06-10 At Loss
2024-08-09 At Loss 2024-06-07 At Loss
2024-08-08 At Loss 2024-06-06 At Loss
2024-08-07 At Loss 2024-06-05 At Loss
2024-08-06 At Loss 2024-06-04 At Loss
2024-08-05 At Loss 2024-06-03 At Loss
2024-08-02 At Loss 2024-05-31 At Loss
2024-08-01 At Loss 2024-05-30 At Loss
2024-07-31 At Loss 2024-05-29 At Loss
2024-07-30 At Loss 2024-05-28 At Loss
2024-07-29 At Loss 2024-05-27 At Loss
2024-07-26 At Loss 2024-05-24 At Loss

RUA Life Sciences PLC (FRA:AOHA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
RUA Life Sciences PLC is a biomedical polymer technology, components, and medical device company. The company's principal activities comprise exploiting the value of its IP and know-how, medical device contract manufacturing, and development of cardiovascular devices. Its business segments are Royalty and License Income (Biomaterials), Contract Manufacture, Product Development (Vascular), and Product Innovation (Structural Heart). It derives the majority of its revenue from the Contract Manufacture segment. Geographically, it derives the majority of its revenue from the USA and has a presence in Switzerland, Italy, the UK, and Israel.